51 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
on validated targets and next-generation cell therapies and biologics in oncology and immunology. Diversifying our pipeline and making clear portfolio … collaboration. We are actively building a deep, early-stage small molecule pipeline addressing multiple targets across a range of indications in our two
6-K
EX-99.15
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
the achievement of pre-established Galapagos targets measured over the three-year performance period and will range from zero if minimum targets are not met … to a maximum of 150% of the target grant. Targets will be set at a level which is appropriately stretching,
11 WWW.GLPG.COM #PioneeringForPatients
6-K
EX-99.1
GLPG
Galapagos NV
4 Jan 24
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
4:07pm
leverages Galapagos’ expertise in small molecule drug discovery and development with BridGene’s innovative discovery platform for “hard-to-drug” targets … this collaboration, Galapagos and BridGene aim to discover and develop new precision medicines against clinically validated oncology targets by leveraging
6-K
EX-99.2
GLPG
Galapagos NV
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
of the year? Can you provide guidance on the full-year 2023 cash burn and any financial targets or projections for the company? Thad: The first six months … . But it’s not just about meeting targets; it’s also about fostering an environment where every voice is valued and heard. Each one of us has the potential
6-K
EX-99.1
nm4hgvto
31 Mar 23
Current report (foreign)
6:05am
6-K
EX-99.1
z0mbt96w3gbnlrkoga
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
kewfp
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
g96vun 2f0y2
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
04xwu5i
14 Jul 21
Current report (foreign)
5:27pm
6-K
EX-99.1
c5eq3g9gj5dwghtxq
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
ln8tl8hxvnug rzwt
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
8g89o6y 56ch16xoyz3
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
ad4k3hnvf9 1v1b3k
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am
6-K
EX-99.2
1a2tkk c9
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
f96i6up0ii1s5xe8
6 Nov 20
Current report (foreign)
10:06am
6-K
EX-99.1
ousnd rcv4nf8qmao
27 Oct 20
Current report (foreign)
12:13pm
6-K
EX-99.1
0h8ktqk0iti 5sejy96s
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am